迪卡斯 DCTH 深 滬
交易中 09-19 12:59:47 美东时间
9.23
+0.180
+1.99%
華盛通- 最 高9.38
- 今 開9.23
- 成交量 12.41万股
- 最 低 9.05
- 昨 收 9.05
- 總市值 2.12亿
- 52周最高 11.745
- 市盈率 靜 --
- 換手率 0.54%
- 52周最低 2.25
- 委 比 98.18%
- 總股本 2292.27万
- 歷史最高 149900800000.00
- 量 比 0.91
- 振 幅 3.65%
- 歷史最低 2.25
- 每 手 1
- 風險率 2.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | 迪卡斯公司宣布在2024年ESMO会议上发布了新数据，证明Hepzato Kit™在转移性脉络膜黑色素瘤亚组中的疗效。
Delcath Systems Announces New Data Presented at Esmo 2024 Demonstrating Efficac...
09-16 20:30
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
"Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, there's some big money down the road."
08-30 21:09
Delcath Systems Reveals Encouraging Uveal Melanoma Study Results
The latest update is out from Delcath Systems (DCTH). Delcath Systems, Inc. has...
08-30 02:57
Delcath stock jumps 15% on Hepzato Kit study publication
Delcath Systems (NASDAQ:DCTH) stock jumped 15% Tuesday after the company reported positive results from a retrospective study of its Hepzato Kit in the treatment of patients with liver metastases from...
08-28 00:12
Stephens & Co. Reiterates Overweight on Delcath Systems, Maintains $25 Price Target
Stephens & Co. analyst Sudan Loganathan reiterates Delcath Systems (NASDAQ:DCTH) with a Overweight and maintains $25 price target.
08-06 23:42
Delcath Systems GAAP EPS of -$0.48 misses by $0.13, revenue of $7.8M beats by $2.38M
Delcath Systems press release (NASDAQ:DCTH): Q2 GAAP EPS of -$0.48 misses by $0.13. Revenue of $7.8M beats by $2.38M. Total revenue for the quarter ended June 30, 2024 was $7.8 million compared to $0....
08-06 04:23
快讯 | 迪卡斯二季度营业收入为776.6万美元，超过IBES估计的523万美元。
Delcath Systems Q2 Revenue USD 7.766 Million Vs. IBES Estimate USD 5.23 Million
08-06 04:01
快讯 | 迪卡斯二季度净利润美元指数-1374.1万，而IBES预估美元指数-904万。
Delcath Systems Q2 Net Income USD -13.741 Million Vs. IBES Estimate USD -9.04 M...
08-06 04:01
